Literature DB >> 32249823

Combination therapy combats aggressive breast cancer.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2020        PMID： 32249823     DOI： 10.1038/d41573-020-00065-5

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors.

Authors:  Johanna M Schafer; Brian D Lehmann; Paula I Gonzalez-Ericsson; Clayton B Marshall; J Scott Beeler; Lindsay N Redman; Hailing Jin; Violeta Sanchez; Matthew C Stubbs; Peggy Scherle; Kimberly N Johnson; Quanhu Sheng; Joseph T Roland; Joshua A Bauer; Yu Shyr; Bapsi Chakravarthy; Bret C Mobley; Scott W Hiebert; Justin M Balko; Melinda E Sanders; Phillip C C Liu; Jennifer A Pietenpol
Journal:  Sci Transl Med       Date:  2020-03-11       Impact factor: 17.956
  1 in total
  1 in total

Review 1.  Oncoimmunology Meets Organs-on-Chip.

Authors:  Fabrizio Mattei; Sara Andreone; Arianna Mencattini; Adele De Ninno; Luca Businaro; Eugenio Martinelli; Giovanna Schiavoni
Journal:  Front Mol Biosci       Date:  2021-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.